<DOC>
	<DOC>NCT00268151</DOC>
	<brief_summary>The purpose of this study is to determine the most suitable dose of Oxaliplatin that can be safely given in combination with a low fixed dose of Capecitabine and a limited volume of radiation in patients with non-small cell lung cancer.</brief_summary>
	<brief_title>Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>The purpose of this study is to determine the maximum tolerated dose (MTD) and the dose limiting toxicity (DLT) of Oxaliplatin in combination with Capecitabine and radiation in subjects with non-small cell lung cancer.</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>histologically proven nonsmall cell lung cancer inoperable Stage III A or B NSCLC must have measurable disease by RECIST criteria no more than one prior chemotherapy for advanced disease ECOG Performance Status of 0, 1, or 2 must be able to swallow pills or have a working gastric feeding tube and no evidence of malabsorption negative serum betaHCG test and under active contraception (for females of childbearing potential) no known allergies to any of the study drugs willingness to sign an informed consent women who are pregnant or breastfeeding ANC of less than 1500/mm3 platelet count of less than 100,000/mm3 estimated creatinine clearance of less than 50 cc/min (as measured by the CockcroftGault equation) bilirubin of less than 2mg/dl SGPT of greater than 2x nl peripheral neuropathy of Grade 2 or higher more than one previous chemotherapy and previous radiation therapy to the chest a history of CHF/MI or other significant cardiac history within the last six months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>capecitabine</keyword>
	<keyword>XELOX-RT</keyword>
</DOC>